Epidemiological Characteristics and Survival Studies of Rhabdomyosarcoma in East Egypt : A Five-Year Multicenter Study

• Published in: ISRN oncology 2012, Vol.2012 (2012), p.1-8
• Main Authors: Badr, M. A., al-Tonbary, Youssef, Mansour, A. K., Hassan, T. H., Beshir, M. R., Darwish, A., El-Ashry, R. A.
• Format: Article
• Language: English
• Subjects: Clinical Study
• ISSN: 2090-5661; 2090-567X; 2090-567X
• DOI: 10.5402/2012/674523

Background. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children, it represents 5–8% of childhood malignancies. Aim of the Work. To evaluate the epidemiological characteristics and treatment outcome in two pediatric oncology centers. Patients and Method. A retrospective analysis was performed on 41 medical records of children with RMS during 6 years period. Results. The median age of patients was 6 years with 80.4% below 10 years. Head and neck was the most common primary site. Embryonal RMS was the most frequent histopathologic subtype. Stage IV was the most frequent stage. According to IRS postsurgical grouping classification, group 4 was the most frequent group. There was a significant relationship between histopathologic subtypes of tumor and metastasis, primary site of tumor and histopathologic subtype, age, metastasis, IRS presurgical stage and IRS postsurgical group and outcome. The overall survival rate was 56.9% ± 8.4 and the failure free survival rate was 68.3% ± 7.6. Conclusion. The epidemiological characteristics of our patients are quite near to the worldwide data, apart from the higher prevalence of stage IV and group 4 with most of the primary tumor site in the extremities. CWS2002 protocol of therapy had led to improvement in the curability of the disease.